Of particular significance, patients with high PBF/Src expression had a significantly higher proportion of HER2-positive and TNBC tumours than those with low PBF/Src expression (Fig. 5F), which was reflected in greater reduction in overall survival (Fig. 5G) compared to other patient groups (Supplementary Fig. 8B). This evidence concerns the gene ERBB2 and neoplasm.